Quality of life and functioning ability in subjects vulnerable to psychosis

Comprehensive Psychiatry

Volumn 48, Issue 2, 2007, Pages 155-160

  Svirskis, Tanja ^a,b   Korkeila, Jyrki ^a,b   Heinimaa, Markus ^a   Huttunen, Jukka ^a,b   Ilonen, Tuula ^a   Ristkari, Terja ^a   Hietala, Jarmo ^a,b,c   Syvälahti, Erkka ^a   McGlashan, Thomas ^d   Vahlberg, Tero ^a   Salokangas, Raimo K R ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b Turku Psychiatric Clinic   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMMUNITY SAMPLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HEINRICHS QUALITY OF LIFE SCALE; HIGH RISK PATIENT; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTIVARIATE ANALYSIS; PSYCHOSIS; QUALITY OF LIFE; RATING SCALE; RISK ASSESSMENT; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT PLANNING;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SOCIAL BEHAVIOR;

EID: 33846781710     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2006.10.008     Document Type: Article

References (27)

1. Katsching H. Schizophrenia and quality of life. Acta Psychiatr Scand 102 Suppl 407 (2000) 33-37
2. Bechdolf A., Pukrop R., Köhn D., Tschinkel S., Veith V., Schulze-Lutter F., et al. Subjective quality of life in persons at high-risk for a first episode psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res 79 (2005) 137-143
3. Yung A.R., Phillips L.J., Yen H.P., and McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 67 (2003) 131-142
4. Ruhrman S., Schulze-Lutter F., Wieneke A., Picker H., Pukrop R., and Hoppmann B. Do patients with a prodromal syndrome cross the threshold of clinical illness?. Schizophr Res 70 Suppl (2004) 37-38
5. Davidson M., Reichenberg M.A., Rabinowitz J., Weiser M., Kaplan Z., and Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 156 (1999) 1328-1335
6. Häfner H., Löffler W., Maurer K., Hambrecht M., and an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 100 (1999) 105-118
7. Cornblatt B.A., Lencz T., Smith C.W., Correll C.U., Auther A.M., and Nakayama E. The schizophrenia prodrome revisited; a neurodevelopmental perspective. Sch Bull 4 29 (2003) 633-651
8. Rabinowitz J., Haim R., Reichenberg A., Weiser M., Kaplan Z., Davidson M., et al. Association between functioning in adolescence prior to first admission for schizophrenia and affective disorders and patterns of hospitalizations thereafter. Schizophr Res 73 (2005) 185-191
9. Pinikahana J., Happel B., Hope J., and Keks N.A. Quality of life in schizophrenia: a review of literature from 1995-2000. Int J Ment Health Nurs 11 (2002) 103-111
10. Lambert M., and Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18 Suppl 2 (2004) 5-7 [discussion 41-3]
11. Norman R.M.G., Malla A.K., McLean T., Voruganti L.P.N., Cortese L., McIntosh E., et al. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and Quality of Life Scale. Acta Psychiatr Scand 102 (2000) 303-309
12. Wegener S., Redoblado-Hodge M.A., Lucas S., Fitzgerald D., Harris A., and Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry 39 (2005) 487-492
13. Salokangas R.K.R., Heinimaa M., Ilonen T., Suomela T., Korkeila J., Plathin M., et al. Epidemiology of prodrome in familial schizophrenia. In: Millet T., et al. (Ed). Early intervention in psychiatric disorders (2001), Kluwer Academic Publishers, Dordrecht, the Netherlands 47-69
14. Salokangas R.K.R., Heinimaa M., Ilonen T., Suomela T., Korkeila J., Plathin M., et al. Vulnerability to and risk of psychosis. Description, experiences and preliminary results of the Detection of Early Psychosis or DEEP project. Neurol Psychiatry Brain Res 11 (2004) 37-44
15. Miller T., McGlashan T., Woods S., Stein K., Driesen N., Corcoran C., et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 70 (1999) 273-289
16. American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington (DC)
17. Heinrichs D., Hanlon T., and Carpenter Jr. W. The Quality of Life Scale: an instrument for rating the schizophrenia deficit syndrome. Schizophr Bull 10 3 (1984) 388-398
18. Svirskis T., Korkeila J., Heinimaa M., Huttunen J., Ilonen T., Ristkari T., et al. Axis-I disorders and vulnerability to psychosis. Schizophr Res 75 (2005) 439-446
19. Zubin J., and Spring B. Vulnerability-a new view of schizophrenia. J Abnorm Psychol 82 (1977) 103-126
20. Pukrop R., Möller H.J., and Steinmeyer E.M. Quality of life in psychiatry. A systematic contribution to construct validation and development of the integrative assessment tool. Modular system of quality of life. Eur Arch Psychiatry Clin Neurosci 250 (2000) 120-132
21. Mason O., Startup M., Halpin S., Schall U., Conrad A., and Carr V. Risk factors for transition to first episode psychosis among individuals with "at-risk mental states". Schizophr Res 71 (2004) 227-237
22. McGorry P., Yung A., Phillips L., Yuen H., Francey S., Cosgrave E., et al. Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59 (2002) 921-928
23. Miller T.J., Zipursky R.B., Perkins D., Addington J., Woods S.W., Hawkins K.A., et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the "prodromal" sample. Schizophr Res 61 (2003) 19-30
24. Browne S., Roe M., Lane A., Gervin M., Morris M., Kinsella A., et al. Quality of life in schizophrenia: relationships to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 94 (1996) 118-124
25. Milev P., Ho B.-C., Arndt S., and Andreasen N. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162 (2005) 495-506
26. Salokangas R.K.R., Räkköläinen V., and Alanen Y.O. Maintenance of grip of life and goals of life: a valuable criterion for evaluating outcome in schizophrenia. Acta Psychiatr Scand 80 (1989) 187-193
27. Kay S.R. The positive and negative symptom scale (PANSS) of schizophrenia. Schizophr Bull 13 (1987) 261-276